Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
OJFord
9 months ago
|
parent
|
context
|
favorite
| on:
First-in-class MKK4 inhibitors enhance liver regen...
Fourth bullet point right at the top is that they've just completed a phase 1 trial. So, outside of the trial, no.
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
